Sidartawan Soegondo

South Tangerang, BT, Indonesia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Glycaemic, cardiorenal, and lipid parameters associated with SGLT2 inhibitors use in Indonesian patients with type 2 diabetes: 12-month multicenter real-world study.

Glycaemic, cardiorenal, and lipid parameters associated with SGLT2 inhibitors use in Indonesian patients with type 2 diabetes: 12-month multicenter real-world study.

Journal: PloS one
Published: February 23, 2026

​​Dapagliflozin vs. Empagliflozin for cardiorenal risk reduction: Real-world paired data and comparative study in Indonesia​ .

​​Dapagliflozin vs. Empagliflozin for cardiorenal risk reduction: Real-world paired data and comparative study in Indonesia​ .

Journal: F1000Research
Published: September 08, 2025

Importance and Management of Non-High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment.

Importance and Management of Non-High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment.

Journal: JACC. Asia
Published: August 14, 2025

Marine nutraceuticals as a source of SIRT1 and NRF2 activators for diabetes and aging-related metabolic disorders.

Marine nutraceuticals as a source of SIRT1 and NRF2 activators for diabetes and aging-related metabolic disorders.

Journal: Diabetology & metabolic syndrome
Published: August 09, 2025

Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management.

Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 01, 2025

Emerging phenotype: Maturity-onset diabetes of the young type 5 (MODY-5) - mechanisms, clinical spectrum, and unmet needs.

Emerging phenotype: Maturity-onset diabetes of the young type 5 (MODY-5) - mechanisms, clinical spectrum, and unmet needs.

Journal: Diabetology & metabolic syndrome
Published: May 08, 2025

Perceptions, attitudes, behaviours and barriers towards obesity among people with obesity and health care professionals in Indonesia: An exploratory online survey.

Perceptions, attitudes, behaviours and barriers towards obesity among people with obesity and health care professionals in Indonesia: An exploratory online survey.

Journal: PloS one
Published: February 26, 2025

Chronic complications risk among type 2 diabetes patients with a family history of diabetes.

Chronic complications risk among type 2 diabetes patients with a family history of diabetes.

Journal: Chronic diseases and translational medicine
Published: February 20, 2023

The urgency in proposing the optimal obesity cutoff value in Indonesian population: A narrative review.

The urgency in proposing the optimal obesity cutoff value in Indonesian population: A narrative review.

Journal: Medicine
Published: January 10, 2023

Obesity in South and Southeast Asia-A new consensus on care and management.

Obesity in South and Southeast Asia-A new consensus on care and management.

Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity
Published: July 12, 2022

Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia.

Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia.

Journal: Diabetes & metabolic syndrome
Published: November 09, 2021

Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide, non-interventional, observational study data pool.

Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide, non-interventional, observational study data pool.

Journal: Journal of diabetes and its complications
Published: September 18, 2015
Showing 1-12 of 18

Last Updated: 09/26/2026